FY27 Cost Sharing Capital Grants (Stage 2)

Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)

Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed)

NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical Trial Required)

General grantmaking to nonprofit organizations; cycles alternate between people-focused funding (poverty alleviation, youth education, improved health outcomes) and an animal-focused cycle (animal welfare/protection). Eligibility and application windows are listed on the foundation's application page.

Must be a 501(c)(3) tax-exempt organization | Must be described in IRS section 509(a)(2) (or in certain cases 509(a)(3)) | Fund recipient organizations based in the United States (foundation funds efforts in United States, Sri Lanka, and India) — see page for scope | Final report must be submitted no more than 60 days after the end of the grant period and is required before a new application is reviewed | The foundation does not fund scholarships or direct financial awards to individuals | The foundation does not fund sectarian activities for religious organizations | The foundation does not fund political causes, candidates, organizations, or campaigns | The foundation does not fund sponsorship of events, conferences, or meetings | The foundation does not fund disease-specific initiatives and/or medical research | The foundation will not fund organizations that discriminate based on age, race, nationality, ethnicity, religion, cultural beliefs, disability, or sex

FY27 Cost Sharing Capital Grants (Stage 2)

Geographic eligibility

Contact & website

assets.montgomerycountymd.gov

Closes in 3 days

Maryland

Similar Grants

Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)

~$820K

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)

~$820K

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)

~$820K

Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed)

~$820K

NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical Trial Required)

~$820K

Chandramohan Family Foundation Grants

~$20K